Aptar Pharma Acquires Pulmotree
The acquisition is expected to accelerate development and commercialization of Kolibri and expand Aptar’s pulmonary drug delivery opportunities.
Related stories
Dr. Reddy’s to Offer Injectable Lenacapavir for $40 per Person Annually
The injectable treatment will be available at that price across 120 countries covered by Gilead’s voluntary licence.
M impact | EQUITY | Nov 02, 2026, 02:15 PM UTC
INIT shares fall 8.4% after results and outlook
INIT shares are down 8.4% and on track for their worst day since March.
M impact | EQUITY | Nov 02, 2026, 02:15 PM UTC
Union Properties quarterly revenue AED 280.2 million
M impact | EQUITY | Nov 02, 2026, 02:15 PM UTC
Union Properties Reports Quarterly Profit of AED 9.7 Million
M impact | EQUITY | Nov 02, 2026, 02:15 PM UTC
IKEA Says It Was Affected by Cybersecurity Incident
IKEA says the incident involved retail refrigeration control systems.
M impact | EQUITY | Nov 02, 2026, 02:15 PM UTC
aap Implantate Plans Private Placement of Unsubscribed Shares at EUR 1.35 Minimum
aap Implantate plans to privately place unsubscribed shares at a minimum price of EUR 1.35 each.
L impact | EQUITY | Nov 02, 2026, 02:14 PM UTC